Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Plus Maraviroc in HIV-Infected Renal Transplant Recipients
NCT02990312Phase 4Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- May 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sirolimus, maraviroc in human immunodeficiency virus infection (HIV), sponsored by University of Maryland, Baltimore. Planned start May 2017; status: withdrawn.
02
Drugs
sirolimusmaraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02990312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02990312.